2013/05/03 by Eamonn Kelly · 2 citations
Biochemistry, Genetics and Molecular Biology · Chemistry · Neuroscience · #Agonist #Biochemistry #Biology #Chemistry #Functional selectivity #G protein-coupled receptor #Intrinsic activity #Neuropeptides and Animal Physiology #Neuroscience #Pharmacological Receptor Mechanisms and Effects #Pharmacology #Receptor #Receptor Mechanisms and Signaling
paper · doi:10.1111/bph.12222
openalex publication_date 2013/05/03 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/15
In order to describe drug action at a GPCR , a full understanding of the pharmacological terms affinity, efficacy and potency is necessary. This is true whether comparing the ability of different agonists to produce a measurable response in a cell or tissue, or determining the relative ability of an agonist to activate a single receptor subtype and produce multiple responses. There is a great deal of interest in the μ‐opioid receptor (MOP receptor) and the ligands that act at this GPCR not only because of the clinically important analgesic effects produced by MOP agonists but also because of their liability to induce adverse effects such as respiratory depression and dependence. Our understanding of the mechanisms underlying these effects, as well as the ability to develop new, more effective MOP receptor drugs, depends upon the accurate determination of the efficacy with which these ligands induce coupling of MOP receptors to downstream signalling events. In this review, which is written with the minimum of mathematical content, the basic meaning of terms including efficacy, intrinsic activity and intrinsic efficacy is discussed, along with their relevance to the field of MOP receptor pharmacology, and in particular in relation to biased agonism at this important GPCR . Linked Articles Recent reviews on aspects of efficacy can be found at: Kenakin, T (2013). New concepts in pharmacological efficacy at 7TM receptors: IUPHAR Review 2. British Journal of Pharmacology 168: 554–575. doi: 10.1111/j.1476‐5381.2012.02223.x Roche D, Gil D and Giraldo J (2013). Mechanistic analysis of the function of agonists and allosteric modulators: reconciling two‐state and operational models. British Journal of Pharmacology 169: 1189–1202. doi: 10.1111/bph.12231